Bandingkan Harga & Kinerja Idea Indonesia Akademi Tbk. (IDEA) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Idea Indonesia Akademi Tbk. dan UBC Medical Indonesia Tbk.: Idea Indonesia Akademi Tbk. diperdagangkan di Rp64 (kapitalisasi pasar 71,18 M, volume 24 jam 5,26 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 8,2× kapitalisasi pasar Idea Indonesia Akademi Tbk., dan Idea Indonesia Akademi Tbk. lebih aktif diperdagangkan (5,26 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| IDEA | LABS | |
|---|---|---|
Kapitalisasi Pasar | 71,18 M | 584,6 M |
Volume | 5,26 jt | 817,3 rb |
Lot | 52,59 rb | 8,17 rb |
Perputaran | 337,78 jt | 120,01 jt |
Harga Rata-rata | 64,22 | 146,84 |
Nilai Transaksi | 337,78 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 64 | 146 |
Volume Ekuilibrium Indikatif | 797 | 59 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Idea Indonesia Akademi Tbk.
PT Idea Indonesia Akademi Tbk (the "Company") was established on August 13, 2019 based on Notarial Deed No. 24 of Panji Kresna, S.H., M.Kn. The Company started its commercial operations in 2019.
Selengkapnya di halaman IDEA →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
